Freudenheim Partners relocates and expands ArkeaBio at 500 Rutherford Ave in Charlestown

500 Rutherford Avenue

Boston – Freudenheim Partners announced that Arkea Bio Corp., a pioneer in developing technology to reduce greenhouse gas (GHG) emissions from the agricultural sector, has relocated and expanded at 500 Rutherford Avenue in Charlestown.

The company will be occupying a 12,461 SF sublease on the third floor of
500 Rutherford Avenue. Ellie Cullinan represented the tenant, ArkeaBio, while Carolyn Wheatley and Zach Gramlich of JLL represented the sublandlord in the transaction.

“ArkeaBio has had a great deal of success with their highly skilled and seasoned team. They were expanding rapidly and needed fully built out lab space for immediate occupancy,” said Ellie Cullinan, Executive Vice President of Freudenheim Partners. “It’s a testament to the evolution of the neighborhood that AkreaBio is joining Indigo AG as agriculture companies ushering the former Hood dairy manufacturing complex into a new
era of life sciences. We are excited to see what ArkeaBio does in its new space.”

500 Rutherford Avenue is a beautifully renovated and landscaped three-story building nestled in Hood Park. The property is a six-minute walk from the Orange Line at the Sullivan Square stop and provides easy access to North Station and Assembly Row. Park amenities include a private tenant lounge, electric vehicle charging stations, fitness center and shuttle to the MBTA.

ArkeaBio is using innovative vaccine technologies to create solutions to reduce the on-farm methane emissions responsible for 6% of global GHG emissions. ArkeaBio technology will be integrated into proven delivery systems and farming practices to safely reduce global methane emissions from multiple ruminant species across a variety of geographies and agronomic systems.